U.S. regulators on Friday approved a new type of cholesterol-lowering drug aimed at millions of people who can't tolerate — or don't get enough help from — widely used statin pills like Lipitor and Crestor.
This undated photo provided by Esperion Inc. shows the cholesterol-lowering drug Nexletol made by Esperion Therapeutics Inc. The Food and Drug Administration on Friday, Feb. 21, 2020 approved Esperion Therapeutics Inc.’s Nexletol for people genetically predisposed to have sky-high cholesterol and others who have heart disease and need to further lower their bad cholesterol.
High LDL, or bad cholesterol, is one of the top risks for heart attacks and other problems. Studies showed that Nexletol could lower LDL by about 25% when taken alone and by an additional 18% when combined with a statin. Far fewer patients use Repatha and Praluent, newer drugs that cost $6,000 or more a year. Insurers often restrict coverage of those medicines, which are shots patients give themselves once or twice a month.
The new drug “would be valuable to add to treatment” for patients who can't get their LDL down enough with existing drugs or can't afford the injected ones, Duke Heart Center co-director Dr. Manesh Patel said. Patel, who was not involved in the research, estimated 10% to 15% of his patients might be eligible for Nexletol.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
FDA Clears New Type of Cholesterol DrugAmericans struggling to lower their cholesterol will have another drug at their disposal, after the FDA approved a new medicine from Esperion Therapeutics.
Les mer »
FDA approves drug that lowers cholesterol in a new wayNexletol was approved for people genetically predisposed to have sky-high cholesterol and people who have heart disease and need to further lower their bad cholesterol.
Les mer »
FDA approves Eli Lilly's Trulicity to reduce cardiovascular risks in type 2 diabetic patientsEli Lilly and Co said on Friday the U.S. Food and Drug Administration has approv...
Les mer »
FDA approves drug that lowers cholesterol in a new wayNexletol was approved for people genetically predisposed to have sky-high cholesterol and people who have heart disease and need to further lower their bad cholesterol.
Les mer »
FDA Clears New Type of Cholesterol DrugAmericans struggling to lower their cholesterol will have another drug at their disposal, after the FDA approved a new medicine from Esperion Therapeutics.
Les mer »
FDA approves Eli Lilly's Trulicity to reduce cardiovascular risks in type 2 diabetic patientsEli Lilly and Co said on Friday the U.S. Food and Drug Administration has approv...
Les mer »